Road walked on:
Marie Buléon received her PhD from the University Paul Sabatier, Toulouse, France, in 2008. From 2004 to 2008 she worked as a PhD student in chronic kidney disease. She was recruited as an Assistant engineer at the Renal Fibrosis Lab, INSERM U1048, in 2009.
Main domains of expertise:
Animal experiments, Acute kidney disease, Chronic kidney disease, Plasma/urine biochemistry
Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Cadoudal T, Buléon M, Sengenès C, Diene G, Desneulin F, Molinas C, Eddiry S, Conte-Auriol F, Daviaud D, Martin PG, Bouloumié A, Salles JP, Tauber M, Valet P. Int J Obes (Lond). 2014. [Read]
Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO). Chaabane W, Praddaude F, Buleon M, Jaafar A, Vallet M, Rischmann P, Galarreta CI, Chevalier RL, Tack I. Am J Physiol Renal Physiol. 2013. [Read]
Type 2 diabetes mellitus in mice aggravates the renal impact of hemorrhagic shock. Dupuy V, Mayeur N, Buléon M, Jaafar A, Al Saati T, Schaak S, Praddaude F, Minville V, Tack I. Shock. 2012. [Read]
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Buléon M, Allard J, Jaafar A, Praddaude F, Dickson Z, Ranera MT, Pecher C, Girolami JP, Tack I. Am J Physiol Renal Physiol. 2008. [Read]